Valuation: Curiosis, Inc.

Market Cap 191B 135M 117M 110M 99.96M 188M 12.88B 191M 1.28B 503M 6.45B 507M 496M 21.51B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 172M 122K 106K 98.98K 90.31K 170K 11.64M 173K 1.16M 455K 5.82M 458K 448K 19.43M EV / Sales 2026 *
11.2x
EV / Sales 2027 * 7.21x
Free-Float
35.64%
Yield 2026 *
-
Yield 2027 * -
1 day+7.76%
1 week+13.33%
Current month+33.55%
1 month-2.53%
3 months-54.30%
6 months-66.97%
Current year-48.98%
1 week 10,830
Extreme 10830
12,700
1 month 8,220
Extreme 8220
16,600
Current year 8,220
Extreme 8220
44,000
1 year 8,220
Extreme 8220
48,200
3 years 8,220
Extreme 8220
48,200
5 years 8,220
Extreme 8220
48,200
10 years 8,220
Extreme 8220
48,200
Manager TitleAgeSince
Chief Executive Officer 55 2014-12-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 55 2014-12-31
Director/Board Member 57 2016-11-30
Director/Board Member 56 2016-11-30
Change 5-day change 1-year change 3-year change Capi.($)
+7.76%+13.33% - - 135M
+0.89%+7.13%+30.84%+11.26% 224B
-0.92%+6.50%+3.84%-18.78% 146B
+2.00%+8.95%-14.97%+31.77% 142B
+1.45%+4.28%-50.18%+0.31% 74.19B
+1.77%+4.53%+19.83%+17.94% 53.99B
-0.58%+1.51%-13.73%-16.11% 50.85B
+0.52%+7.39%+30.98%+17.84% 42.22B
+0.78%+4.78%+48.59%+42.29% 40.75B
-0.26%+3.54%-0.34%+1.62% 32.86B
Average +1.34%+199.36%+6.10%+9.79% 80.63B
Weighted average by Cap. +0.70%+312.74%+6.53%+8.67%

Financials

2026 *2027 *
Net sales 15.4B 10.9M 9.45M 8.84M 8.07M 15.19M 1.04B 15.44M 104M 40.63M 520M 40.93M 40.04M 1.74B 23.9B 16.92M 14.66M 13.73M 12.52M 23.57M 1.61B 23.96M 161M 63.06M 808M 63.53M 62.14M 2.69B
Net income - -
Net Debt -18.4B -13.03M -11.29M -10.57M -9.64M -18.14M -1.24B -18.45M -124M -48.55M -622M -48.91M -47.84M -2.07B -18.4B -13.03M -11.29M -10.57M -9.64M -18.14M -1.24B -18.45M -124M -48.55M -622M -48.91M -47.84M -2.07B
Logo Curiosis, Inc.
Curiosis Inc is a Korea-based company principally engaged in the development and manufacture of bioresearch equipment, lab automation products, and medical devices. The Company is mainly engaged in the development and manufacture of bio research equipment for implementing lab automation based on bioengineering and automation control technologies, such as automated live-cell imaging systems. Additionally, the Company is engaged in the development and manufacture of lab automation systems including colony picking systems, digital pathology scanners, as well as automated cell concentration and separation systems. The Company is engaged in the manufacture and sales of cell counters and aesthetic medical devices as well.
Employees
-
Date Price Change Volume
26-08-11 ₩12,500.00 +7.76% 221,932
26-08-10 ₩11,600.00 +1.22% 208,920
26-08-07 ₩11,460.00 -0.69% 98,324
26-08-06 ₩11,540.00 +2.58% 90,469
26-08-05 ₩11,250.00 +1.99% 73,397
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A494120 Stock